What is PharmaCentra?
Established in 2003, PharmaCentra operates as a specialized provider of contact center solutions engineered specifically for the pharmaceutical, insurance, and clinical research industries. By bridging the communication gap between patients, healthcare providers, and pharmacies, the company facilitates critical functions such as clinical trial recruitment and pharmacy locator services. With a portfolio supporting over 150 brands, PharmaCentra leverages its deep domain expertise to deliver flexible, high-quality engagement strategies that address the nuanced regulatory and operational requirements of the modern healthcare landscape.
How much funding has PharmaCentra raised?
PharmaCentra has raised a total of $570K across 1 funding round:
Debt
$570K
Debt (2021): $570K with participation from PPP
Key Investors in PharmaCentra
PPP
Public-Private Partnership
What's next for PharmaCentra?
The recent capital allocation is expected to catalyze further expansion of PharmaCentra's service offerings, particularly as the demand for integrated healthcare management solutions continues to rise. By prioritizing technological infrastructure and operational agility, the company is well-positioned to capture additional market share within the clinical research and patient support verticals. Future growth will likely focus on enhancing digital patient engagement tools and scaling its contact center capabilities to meet the increasing complexity of global healthcare delivery models, ensuring the firm remains a preferred partner for enterprise-level pharmaceutical brands.
See full PharmaCentra company page
